DK0821673T3 - Ny form af (E)-3-[6-[[2,6-dichlorphenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propensyre - Google Patents
Ny form af (E)-3-[6-[[2,6-dichlorphenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propensyreInfo
- Publication number
- DK0821673T3 DK0821673T3 DK96914877T DK96914877T DK0821673T3 DK 0821673 T3 DK0821673 T3 DK 0821673T3 DK 96914877 T DK96914877 T DK 96914877T DK 96914877 T DK96914877 T DK 96914877T DK 0821673 T3 DK0821673 T3 DK 0821673T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenylethoxy
- dichlorophenyl
- pyridinyl
- thio
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9508137.8A GB9508137D0 (en) | 1995-04-21 | 1995-04-21 | Formulation |
PCT/EP1996/001466 WO1996033174A1 (en) | 1995-04-21 | 1996-04-02 | New form of (e)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0821673T3 true DK0821673T3 (da) | 2001-06-18 |
Family
ID=10773317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96914877T DK0821673T3 (da) | 1995-04-21 | 1996-04-02 | Ny form af (E)-3-[6-[[2,6-dichlorphenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propensyre |
Country Status (23)
Country | Link |
---|---|
US (1) | US6093828A (pt) |
EP (1) | EP0821673B1 (pt) |
JP (1) | JPH11503737A (pt) |
KR (1) | KR19990007900A (pt) |
CN (1) | CN1182418A (pt) |
AT (1) | ATE198883T1 (pt) |
AU (1) | AU707089B2 (pt) |
BR (1) | BR9608003A (pt) |
CA (1) | CA2218322A1 (pt) |
CZ (1) | CZ333797A3 (pt) |
DE (1) | DE69611670T2 (pt) |
DK (1) | DK0821673T3 (pt) |
ES (1) | ES2154818T3 (pt) |
GB (1) | GB9508137D0 (pt) |
GR (1) | GR3035494T3 (pt) |
HU (1) | HUP9801574A3 (pt) |
NO (1) | NO309767B1 (pt) |
NZ (1) | NZ307493A (pt) |
PL (1) | PL322897A1 (pt) |
PT (1) | PT821673E (pt) |
TR (1) | TR199701213T1 (pt) |
WO (1) | WO1996033174A1 (pt) |
ZA (1) | ZA963134B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9602675D0 (en) * | 1996-02-09 | 1996-04-10 | Smithkline Beecham Plc | Process |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2119467A1 (en) * | 1991-09-19 | 1993-04-01 | Pamela Anne Chambers | Pyridine compounds for treating leukotriene-related diseases |
AU678979B2 (en) * | 1992-06-30 | 1997-06-19 | Smithkline Beecham Corporation | Process for making phenylthiomethylpyridinylalkenoates |
MA22926A1 (fr) * | 1992-06-30 | 1994-04-01 | Smithkline Beecham Corp | Procede pour la preparation de nouveaux composes. |
GB9313145D0 (en) * | 1993-06-25 | 1993-08-11 | Smithkline Beecham Plc | Process |
-
1995
- 1995-04-21 GB GBGB9508137.8A patent/GB9508137D0/en active Pending
-
1996
- 1996-04-02 DK DK96914877T patent/DK0821673T3/da active
- 1996-04-02 PT PT96914877T patent/PT821673E/pt unknown
- 1996-04-02 ES ES96914877T patent/ES2154818T3/es not_active Expired - Lifetime
- 1996-04-02 US US08/945,372 patent/US6093828A/en not_active Expired - Fee Related
- 1996-04-02 HU HU9801574A patent/HUP9801574A3/hu unknown
- 1996-04-02 JP JP8531444A patent/JPH11503737A/ja active Pending
- 1996-04-02 EP EP96914877A patent/EP0821673B1/en not_active Expired - Lifetime
- 1996-04-02 NZ NZ307493A patent/NZ307493A/en unknown
- 1996-04-02 WO PCT/EP1996/001466 patent/WO1996033174A1/en not_active Application Discontinuation
- 1996-04-02 CN CN96193405A patent/CN1182418A/zh active Pending
- 1996-04-02 KR KR1019970707423A patent/KR19990007900A/ko not_active Application Discontinuation
- 1996-04-02 AU AU56859/96A patent/AU707089B2/en not_active Ceased
- 1996-04-02 PL PL96322897A patent/PL322897A1/xx unknown
- 1996-04-02 DE DE69611670T patent/DE69611670T2/de not_active Expired - Fee Related
- 1996-04-02 CA CA002218322A patent/CA2218322A1/en not_active Abandoned
- 1996-04-02 CZ CZ973337A patent/CZ333797A3/cs unknown
- 1996-04-02 TR TR97/01213T patent/TR199701213T1/xx unknown
- 1996-04-02 AT AT96914877T patent/ATE198883T1/de active
- 1996-04-02 BR BR9608003A patent/BR9608003A/pt active Search and Examination
- 1996-04-19 ZA ZA9603134A patent/ZA963134B/xx unknown
-
1997
- 1997-10-20 NO NO974840A patent/NO309767B1/no not_active IP Right Cessation
-
2001
- 2001-02-28 GR GR20010400337T patent/GR3035494T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO309767B1 (no) | 2001-03-26 |
DE69611670D1 (en) | 2001-03-01 |
TR199701213T1 (pt) | 1998-03-21 |
CN1182418A (zh) | 1998-05-20 |
AU707089B2 (en) | 1999-07-01 |
DE69611670T2 (de) | 2001-08-23 |
JPH11503737A (ja) | 1999-03-30 |
ES2154818T3 (es) | 2001-04-16 |
HUP9801574A2 (hu) | 1998-11-30 |
BR9608003A (pt) | 1999-01-05 |
US6093828A (en) | 2000-07-25 |
EP0821673B1 (en) | 2001-01-24 |
EP0821673A1 (en) | 1998-02-04 |
GR3035494T3 (en) | 2001-05-31 |
PL322897A1 (en) | 1998-03-02 |
ZA963134B (en) | 1997-02-14 |
CZ333797A3 (cs) | 1999-01-13 |
PT821673E (pt) | 2001-05-31 |
NZ307493A (en) | 1998-07-28 |
HUP9801574A3 (en) | 1998-12-28 |
KR19990007900A (ko) | 1999-01-25 |
WO1996033174A1 (en) | 1996-10-24 |
CA2218322A1 (en) | 1996-10-24 |
AU5685996A (en) | 1996-11-07 |
NO974840L (no) | 1997-10-20 |
GB9508137D0 (en) | 1995-06-07 |
ATE198883T1 (de) | 2001-02-15 |
NO974840D0 (no) | 1997-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0509019T3 (da) | Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin | |
DK0833839T3 (da) | Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme | |
TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
DK0882021T3 (da) | Nye phenanthridiner | |
NL300128I1 (nl) | Gesubstitueerde isoxyzolen voor de behandeling vanontsteking. | |
FI963450A0 (fi) | Morfoliinitakykiniinireseptoriantagonistien lääke-esiastetta | |
ID22042A (id) | Benzonaftiridin sebagai pengobatan cabang tenggorokan | |
AU5648496A (en) | Pyrazolo-(1,5a)pyrimidines, their preparation and their use | |
NO20015122L (no) | Behandling av fibrose ved anvendelse av en antagonist for integrin <alfa>-4-subenheten | |
RS50129B (sr) | Optički aktivan derivat piridil-4h-1,2,4-oksadiazina i njegova upotreba u proizvodnji lekova za tretiranje vaskularnih bolesti | |
DK0821673T3 (da) | Ny form af (E)-3-[6-[[2,6-dichlorphenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propensyre | |
PT783495E (pt) | Derivados de quinoxalina uteis em terapia | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
PT775143E (pt) | Novos derivados de 3h-2,3-benzodiazepina 3-substituidos sua preparacao e utilizacao | |
KR890006621A (ko) | 항불안제 | |
BR0016941A (pt) | Derivados de aminometil-fenil-ciclohexanona | |
DK0537313T3 (da) | Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet | |
ATE216702T1 (de) | Silylierungsprocess | |
MX9708089A (es) | Compuestos. | |
AU3868895A (en) | Process for the preparation of furosemide | |
DK0808306T3 (da) | Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo | |
FR2657005B1 (fr) | Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes. | |
NO974687D0 (no) | Kondenserte <beta>-carboliner | |
UA7134C2 (uk) | Спосіб терапевтичної дії на біологічні об'єкти та пристрій для його здійснення | |
TW233244B (pt) |